Skip to main content

5 Result(s)

within J. J. V. McMurray Remove this filter

and

  1. Article

    Open Access

    “Real World” Eligibility for Sacubitril/Valsartan in Unselected Heart Failure Patients: Data from the Swedish Heart Failure Registry

    PARADIGM-HF demonstrated the superiority of sacubitril/valsartan over enalapril in patients with heart failure and reduced ejection fraction (HF-REF). How widely applicable sacubitril/valsartan treatment is in...

    Joanne Simpson, L. Benson, P. S. Jhund, U. Dahlström… in Cardiovascular Drugs and Therapy (2019)

    Download PDF (338 KB) View Article

  2. No Access

    Article

    The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data

    In heart failure (HF), obesity, defined as body mass index (BMI) ⩾30 kg m−2, is paradoxically associated with higher survival rates compared with normal-weight patients (the ‘obesity paradox’). We sought to deter...

    R Padwal, F A McAlister, J J V McMurray, M R Cowie… in International Journal of Obesity (2014)

  3. No Access

    Article

    Clinical Trials Update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY

    The Clinical Trials described in this article were presented at the Hotline and Clinical Trial Update Sessions of the European Society of Cardiology Congress held in September 2007 in Vienna, Austria. The sess...

    A. Recio-Mayoral, J.-C. Kaski, J. J. V. McMurray… in Cardiovascular Drugs and Therapy (2007)

  4. No Access

    Chapter

    Genetic Determinants of Susceptibility, Prognosis and Treatment in Heart Failure

    Heart failure is a major burden on public health resources and the prevalence of the condition is rising as the population ages and with the increasing success of salvage strategies for myocardial infarction. ...

    T. Stanton, J. M. C. Connell, J. J. V. McMurray in Cardiovascular Pharmacogenetics (2004)

  5. No Access

    Article

    Endothelin in congestive heart failure

    The endothelin (ET) family of peptides have potent vascular, cardiac and renal actions which may be of pathophysiological importance in congestive heart failure (CHF).In vivo studies with selective and non-select...

    M. P. Love, J. J. V. McMurray in Basic Research in Cardiology (1996)